Cargando…
Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting
The 9th Bone and the Oncologist New Updates conference was held in Ottawa, Canada during 2014. This annual meeting focuses on innovative research into the mechanisms and consequences of treatment-induced and metastatic bone disease. Given the recent presentation of the Oxford overview's “Effect...
Autores principales: | Jacobs, Carmel, Amir, Eitan, Paterson, Alexander, Zhu, Xiaofu, Clemons, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620967/ https://www.ncbi.nlm.nih.gov/pubmed/26579489 http://dx.doi.org/10.1016/j.jbo.2015.06.001 |
Ejemplares similares
-
Abstracts of the 2021 Canadian Association of Medical Oncologists Annual Meeting
por: Loree, Jonathan, et al.
Publicado: (2021) -
Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting
por: Zhu, Xiaofu, et al.
Publicado: (2014) -
Meeting now suggests we will meet again: Implications for debates on the evolution of cooperation
por: Krasnow, Max M., et al.
Publicado: (2013) -
How Canadian Oncologists Use Oncotype DX for Treatment of Breast Cancer Patients
por: Zhu, Xiaofu, et al.
Publicado: (2021) -
Abstracts of the 2022 Canadian Association of Medical Oncologists Annual Scientific Meeting †
por: Ezeife, Doreen, et al.
Publicado: (2022)